Market Tracker

01/20 5:16pm ET

Nektar Therapeutics (NASDAQ:NKTR)

12.02
Delayed Data
As of Jan 20
 -0.23 / -1.88%
Today’s Change
10.52
Today|||52-Week Range
19.98
-2.04%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.25
Today’s open12.19
Day’s range11.94 - 12.26
Volume1,536,311
Average volume (3 months)1,652,815
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-78.92%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book252.95

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+1.23+2.20%
RDUSRadius Health Inc+0.03+0.07%
EXASExact Sciences Corp-0.33-1.79%
JUNOJuno Therapeutics In...-0.16-0.81%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts